<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36008057</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Nutritional therapy in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e064086</StartPage><MedlinePgn>e064086</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e064086</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-064086</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease characterised by the degeneration of motor neurons. Nutritional interventions in ALS are essential and must be based on scientific evidence to provide quality of healthcare, improve the quality of life and increase survival time. Therefore, this protocol of systematic reviews and meta-analyses aims to present a synthesis of evidence-based recommendations to support adequate nutrition therapy for patients with ALS.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">The search will be performed using the following databases: PubMed, Excerpta Medica Database (Embase), Scopus, SciELO, Web of Science, LILACS, Cochrane Central Register of Controlled Trials (CENTRAL), ScienceDirect, ProQuest and Google Scholar. We will include clinical practice guidelines, treatment protocols, systematic reviews and clinical trials according to the three research questions to be answered related to nutrition therapy and interventions in patients with ALS. This protocol will be developed in accordance with the Preferred Reporting Items for Systematic Review and Meta-analysis Protocols. To evaluate the methodological quality of the studies, Appraisal of Guidelines, Research and Evaluation II, Cochrane Risk of Bias 2.0 and Risk of Bias In Non-randomized Studies of Interventions (ROBINS-I) tools will be used. In addition, the Grading of Recommendations Assessment, Development and Evaluation will be used to assess the quality of evidence and the strength of the recommendations. The findings will be summarised and presented descriptively according to the Cochrane Collaboration Handbook and the standard statistical meta-analysis techniques.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">Ethical approval and human consent are not required because this is a protocol for systematic review and only secondary data will be used. Findings will be published in a peer-reviewed journal and presented at conferences. In case of any changes in this protocol, amendments will be updated in International Prospective Register of Systematic Reviews (PROSPERO) and the modifications will be explained in the final report of this review.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER">CRD42021233088.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vilar</LastName><ForeName>Mariana Dantas de Carvalho</ForeName><Initials>MDC</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coutinho</LastName><ForeName>Karla Monica Dantas</ForeName><Initials>KMD</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vale</LastName><ForeName>Sancha Helena de Lima</ForeName><Initials>SHL</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nutrition, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medeiros</LastName><ForeName>Gidyenne Christine Bandeira Silva</ForeName><Initials>GCBS</Initials><AffiliationInfo><Affiliation>Department of Nutrition, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systematic Review and Meta-Analysis Laboratory (LabSys), Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piuvezam</LastName><ForeName>Grasiela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Systematic Review and Meta-Analysis Laboratory (LabSys), Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leite-Lais</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8061-7048</Identifier><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte, Natal, Brazil lucia.leite@ufrn.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nutrition, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandao-Neto</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044623" MajorTopicYN="Y">Nutrition Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NUTRITION &amp; DIETETICS</Keyword><Keyword MajorTopicYN="N">Neuromuscular disease</Keyword><Keyword MajorTopicYN="N">Protocols &amp; guidelines</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>21</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36008057</ArticleId><ArticleId IdType="pmc">PMC9422859</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-064086</ArticleId><ArticleId IdType="pii">bmjopen-2022-064086</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 2017;377:162&#x2013;72. 10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ. Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expression. Curr Opin Neurol 2017;30:599&#x2013;607. 10.1097/WCO.0000000000000488</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000488</ArticleId><ArticleId IdType="pubmed">28914734</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Liu T, Liu L, et al. . Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol 2020;267:944&#x2013;53. 10.1007/s00415-019-09652-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09652-y</ArticleId><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD . Motor neuron disease Collaborators. global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 2016;17:1083&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234315</ArticleId><ArticleId IdType="pubmed">30409709</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, et al. . Amyotrophic lateral sclerosis. Lancet 2017;390:2084&#x2013;98. 10.1016/S0140-6736(17)31287-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis DA, Cox PA, Banack SA, et al. . L-Serine reduces spinal cord pathology in a vervet model of preclinical ALS/MND. J Neuropathol Exp Neurol 2020;79:393&#x2013;406. 10.1093/jnen/nlaa002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlaa002</ArticleId><ArticleId IdType="pmc">PMC7092359</ArticleId><ArticleId IdType="pubmed">32077471</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, et al. . Amyotrophic lateral sclerosis. Lancet 2011;377:942&#x2013;55. 10.1016/S0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Bai Z, Qin X, et al. . Aberrations in oxidative stress markers in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Oxid Med Cell Longev 2019;2019:1712323. 10.1155/2019/1712323</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/1712323</ArticleId><ArticleId IdType="pmc">PMC6590548</ArticleId><ArticleId IdType="pubmed">31281567</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscaritoli M, Kushta I, Molfino A, et al. . Nutritional and metabolic support in patients with amyotrophic lateral sclerosis. Nutrition 2012;28:959&#x2013;66. 10.1016/j.nut.2012.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2012.01.011</ArticleId><ArticleId IdType="pubmed">22677356</ArticleId></ArticleIdList></Reference><Reference><Citation>Piquet MA. Approche nutritionnelle des patients atteints de Scl&#xe9;rose Lat&#xe9;rale Amyotrophique [Nutritional approach for patients with amyotrophic lateral sclerosis]. Rev Neurol;162 Spec No 2:4S177&#x2013;4S187.</Citation><ArticleIdList><ArticleId IdType="pubmed">17128108</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Desport JC, Kajeu P, et al. . Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 2011;82:628&#x2013;34. 10.1136/jnnp.2010.211474</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.211474</ArticleId><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Roubeau V, Blasco H, Maillot F, et al. . Nutritional assessment of amyotrophic lateral sclerosis in routine practice: value of weighing and bioelectrical impedance analysis. Muscle Nerve 2015;51:479&#x2013;84. 10.1002/mus.24419</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24419</ArticleId><ArticleId IdType="pubmed">25130859</ArticleId></ArticleIdList></Reference><Reference><Citation>EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis: Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol 2012;19:360&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida CS, Stanich P, Salvioni CCS, et al. . Assessment and nutrition education in patients with amyotrophic lateral sclerosis. Arq Neuropsiquiatr 2016;74:902&#x2013;8. 10.1590/0004-282X20160145</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X20160145</ArticleId><ArticleId IdType="pubmed">27901255</ArticleId></ArticleIdList></Reference><Reference><Citation>Prado LdeGR, Bicalho ICS, Vidigal-Lopes M, et al. . Depression and anxiety in a case series of amyotrophic lateral sclerosis: frequency and association with clinical features. Einstein 2017;15:58&#x2013;60. 10.1590/S1679-45082017AO3870</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1679-45082017AO3870</ArticleId><ArticleId IdType="pmc">PMC5433308</ArticleId><ArticleId IdType="pubmed">28444090</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos CF, Gromicho M, Uysal H, et al. . Family history of neurodegenerative disorders in patients with amyotrophic lateral sclerosis: population-based case-control study. J Neurol Neurosurg Psychiatry 2020;91:671&#x2013;2. 10.1136/jnnp-2019-322561</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322561</ArticleId><ArticleId IdType="pubmed">32165374</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Bogaert E, Dewil M, et al. . Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci U S A 2007;104:14825&#x2013;30. 10.1073/pnas.0705046104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0705046104</ArticleId><ArticleId IdType="pmc">PMC1976195</ArticleId><ArticleId IdType="pubmed">17804792</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers MC, Florez ID, McNair SA, et al. . Clinical practice guidelines: tools to support high quality patient care. Semin Nucl Med 2019;49:145&#x2013;52. 10.1053/j.semnuclmed.2018.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semnuclmed.2018.11.001</ArticleId><ArticleId IdType="pubmed">30819394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kredo T, Bernhardsson S, Machingaidze S, et al. . Guide to clinical practice guidelines: the current state of play. Int J Qual Health Care 2016;28:122&#x2013;8. 10.1093/intqhc/mzv115</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzv115</ArticleId><ArticleId IdType="pmc">PMC4767049</ArticleId><ArticleId IdType="pubmed">26796486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghorob A, Bodenheimer T. Sharing the care to improve access to primary care. N Engl J Med 2012;366:1955&#x2013;7. 10.1056/NEJMp1202775</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1202775</ArticleId><ArticleId IdType="pubmed">22621625</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317&#x2013;22. 10.1016/0140-6736(93)92244-n</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(93)92244-n</ArticleId><ArticleId IdType="pubmed">7901634</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, et al. . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;350:g7647. 10.1136/bmj.g7647</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7647</ArticleId><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers MC, Kho ME, Browman GP, et al. . Agree II: advancing Guideline development, reporting and evaluation in health care. CMAJ 2010;182:E839&#x2013;42. 10.1503/cmaj.090449</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.090449</ArticleId><ArticleId IdType="pmc">PMC3001530</ArticleId><ArticleId IdType="pubmed">20603348</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, et al. . Rob 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898. 10.1136/bmj.l4898</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, et al. . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919. 10.1136/bmj.i4919</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas-Garcia R, Scott KM, et al. . A proposed staging system for amyotrophic lateral sclerosis. Brain 2012;135:847&#x2013;52. 10.1093/brain/awr351</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr351</ArticleId><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Jones A, Jivraj N, et al. . Estimating clinical stage of amyotrophic lateral sclerosis from the ALS functional rating scale. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:279&#x2013;84. 10.3109/21678421.2014.897357</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.897357</ArticleId><ArticleId IdType="pubmed">24720420</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. . Grade: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924&#x2013;6. 10.1136/bmj.39489.470347.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgos R, Bret&#xf3;n I, Cereda E, et al. . ESPEN guideline clinical nutrition in neurology. Clin Nutr 2018;37:354&#x2013;96. 10.1016/j.clnu.2017.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2017.09.003</ArticleId><ArticleId IdType="pubmed">29274834</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 2020;27:1918&#x2013;29. 10.1111/ene.14393</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Cypionka J, Ludolph AC. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:533&#x2013;6. 10.3109/21678421.2013.823999</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.823999</ArticleId><ArticleId IdType="pubmed">23944684</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, Alexander M, Corr B, et al. . Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003;74:1258&#x2013;61. 10.1136/jnnp.74.9.1258</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.74.9.1258</ArticleId><ArticleId IdType="pmc">PMC1738639</ArticleId><ArticleId IdType="pubmed">12933930</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, et al. . Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1218&#x2013;26. 10.1212/WNL.0b013e3181bc0141</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc0141</ArticleId><ArticleId IdType="pmc">PMC2764727</ArticleId><ArticleId IdType="pubmed">19822872</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellogg J, Bottman L, Arra EJ, et al. . Nutrition management methods effective in increasing weight, survival time and functional status in ALS patients: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener 2018;19:7&#x2013;11. 10.1080/21678421.2017.1360355</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1360355</ArticleId><ArticleId IdType="pubmed">28799809</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Hardiman O, et al. . Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009;10:310&#x2013;23. 10.3109/17482960802566824</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Genton L, Viatte V, Janssens J-P, et al. . Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients. Clin Nutr 2011;30:553&#x2013;9. 10.1016/j.clnu.2011.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2011.06.004</ArticleId><ArticleId IdType="pubmed">21798636</ArticleId></ArticleIdList></Reference><Reference><Citation>Espa&#xf1;a GMde, Sanidad Mde. Servicios Sociales E Igualdad. Estrategia en Enfermedades neurol&#xf3;gicas del Sistema Nacional de Salud. Abril 2016.</Citation></Reference><Reference><Citation>Greenwood DI. Nutrition management of amyotrophic lateral sclerosis. Nutr Clin Pract 2013;28:392&#x2013;9. 10.1177/0884533613476554</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0884533613476554</ArticleId><ArticleId IdType="pubmed">23466470</ArticleId></ArticleIdList></Reference><Reference><Citation>National Clinical Guideline Centre (UK) . Motor neurone disease: assessment and management. London: National Institute for Health and Care Excellence (UK), 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">26962594</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Olmo Garc&#xed;a M &#xaa; Dolores, Virgili Casas N, Cant&#xf3;n Blanco A, et al. . [Nutritional management of amyotrophic lateral sclerosis: summary of recommendations]. Nutr Hosp 2018;35:1243&#x2013;51. 10.20960/nh.2162</Citation><ArticleIdList><ArticleId IdType="doi">10.20960/nh.2162</ArticleId><ArticleId IdType="pubmed">30307310</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>